Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [921]
News [3774]
Articles [25]
Editorials [1]
Conferences [142]
elearning [0]
Therapy of Ph-positive adult ALL
Prof Oliver Ottmann - Cardiff University, Cardiff, UK
Therapy of Ph-positive adult ALL ( Prof Oliver Ottmann - Cardiff University, Cardiff, UK )
23 Jan 2020
Targeting CD70 with cusatuzumab eliminates acute myeloid leukaemia stem cells...
Prof Adrian Ochsenbein - University and University Hospital of Bern, Bern...
Targeting CD70 with cusatuzumab eliminates acute myeloid leukaemia stem cells in humans ( Prof Adrian Ochsenbein - University and University Hospital of Bern, Bern, Switzerland )
19 Dec 2019
Clinical outcomes of patients with FLT3-ITD-mutated R/R AML undergoing HSCT...
Dr Siddhartha Ganguly - The University of Kansas Health System, Kansas City, USA
Clinical outcomes of patients with FLT3-ITD-mutated R/R AML undergoing HSCT after quizartinib or salvage chemo ( Dr Siddhartha Ganguly - The University of Kansas Health System, Kansas City, USA )
19 Dec 2019
Outcomes in patients with therapy-Related AML who achieved remission with CPX...
Dr Jeffrey Lancet - H. Lee Moffitt Cancer Center & Research Institute, Tampa...
Outcomes in patients with therapy-Related AML who achieved remission with CPX-351 versus 7 plus 3: Phase 3 exploratory analysis ( Dr Jeffrey Lancet - H. Lee Moffitt Cancer Center & Research Institute, Tampa, USA )
19 Dec 2019
Multiple myeloma: Anti-BCMA BiTE AMG 701 shows preclinical promise
Dr Yu-Tzu Tai - Dana-Farber Cancer Institute, Boston, USA
Multiple myeloma: Anti-BCMA BiTE AMG 701 shows preclinical promise ( Dr Yu-Tzu Tai - Dana-Farber Cancer Institute, Boston, USA )
8 Dec 2019
Bispecific CAR T-cell therapy as treatment for hard to treat multiple myeloma
Dr Yu Hu - Huazhong University of Science and Technology, Wuhan, China
Bispecific CAR T-cell therapy as treatment for hard to treat multiple myeloma ( Dr Yu Hu - Huazhong University of Science and Technology, Wuhan, China )
7 Dec 2019
CAR T-cell therapy in hard-to-treat multiple myeloma produces sustained...
Dr Yu Hu - Huazhong University of Science and Technology, Wuhan, China
CAR T-cell therapy in hard-to-treat multiple myeloma produces sustained remissions ( Dr Yu Hu - Huazhong University of Science and Technology, Wuhan, China )
7 Dec 2019
Immunotherapy and targeted agents for elderly lung cancer patients
Dr Lore Decoster - University Hospital Brussels, Brussels, Belgium
Immunotherapy and targeted agents for elderly lung cancer patients ( Dr Lore Decoster - University Hospital Brussels, Brussels, Belgium )
28 Nov 2019
The use of radiation therapy in older adults
Dr Noam VanderWalde - University of Tennessee West Cancer Center., Memphis, USA
The use of radiation therapy in older adults ( Dr Noam VanderWalde - University of Tennessee West Cancer Center., Memphis, USA )
22 Nov 2019
The cancer groundshot: Going global before going to the moon
Dr Bishal Gyawali - Queen's University, Kingston, Canada
The cancer groundshot: Going global before going to the moon ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
7 Nov 2019
Shaping the future of metastasis - ecancer investigates
Monique Biryiana - ecancer Medical Reporter, Dr Chris Bakal - Dynamical Cell...
Shaping the future of metastasis - ecancer investigates ( Monique Biryiana - ecancer Medical Reporter, Dr Chris Bakal - Dynamical Cell Systems Team Leader, Patricia Pascual Vargas - PhD Student )
14 Oct 2019
Comment: Immunogenicity of biosimilars
Prof Arnold Vulto - Erasmus University Rotterdam, Rotterdam, Netherlands
Comment: Immunogenicity of biosimilars ( Prof Arnold Vulto - Erasmus University Rotterdam, Rotterdam, Netherlands )
8 Oct 2019

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation